文献速递腹部泌尿生殖CT

对比增强CT在膀胱副神经节瘤与膀胱癌鉴别诊断中的价值

Contrast-enhanced CT in the differential diagnosis of bladder cancer and paraganglioma.
PubMed 文献 · Abdom Radiol (NY) · 2024-03-19

回顾性分析19例膀胱副神经节瘤(BPG)与56例膀胱癌患者的CT资料,发现年龄、钙化、蒂、内部血管及邻近供血动脉增粗在两组间有显著差异;皮髓质期CT值和强化值BPG均显著高于膀胱癌,对应AUC为0.930和0.912,最佳阈值分别为83.2 HU和38.5 HU,敏感度78.9%和89.5%,特异度94.6%和75.0%。

要点

  • 皮髓质期CT值>83.2 HU提示BPG,敏感度78.9%、特异度94.6%。
  • 皮髓质期强化值>38.5 HU提示BPG,敏感度89.5%、特异度75.0%。
  • BPG更多见内部血管(15/19 vs 19/56)和邻近供血动脉增粗(14/19 vs 10/56),膀胱癌更多见钙化(18/56 vs 1/19)和蒂(10/56 vs 0/19)。

核心结论

  • 皮髓质期对比增强CT在BPG与膀胱癌的术前鉴别诊断中具有重要价值。

研究设计与样本

  • 回顾性研究,纳入2007年11月至2023年6月间19例BPG(男13例、女6例)和56例膀胱癌(男49例、女7例)患者,均行平扫及对比增强CT扫描。

关键影像表现/征象

  • BPG患者年龄46.4±11.1岁,膀胱癌患者58.6±16.0岁。
  • 肿瘤钙化BPG 1/19 vs 膀胱癌18/56,蒂BPG 0/19 vs 膀胱癌10/56。
  • 内部血管BPG 15/19 vs 膀胱癌19/56,邻近供血动脉增粗BPG 14/19 vs 膀胱癌10/56。
  • 皮髓质期CT值BPG 92.4±16.6 HU vs 膀胱癌64.0±14.5 HU,BPG更高。
  • 皮髓质期强化值BPG 54.5±17.4 HU vs 膀胱癌28.5±12.8 HU,BPG更高。

诊断标准与关键数值

  • 皮髓质期CT值鉴别BPG与膀胱癌的AUC为0.930,最佳阈值83.2 HU,敏感度78.9%,特异度94.6%。
  • 皮髓质期强化值鉴别BPG与膀胱癌的AUC为0.912,最佳阈值38.5 HU,敏感度89.5%,特异度75.0%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: We sought to summarize the value of contrast-enhanced computed tomography (CECT) in the differential diagnosis of bladder paraganglioma (BPG) and bladder cancer.

METHODS: The medical records of 19 patients with BPG (13 males, 6 females) and 56 patients with bladder cancer (49 males, 7 females) between November 2007 and June 2023 were retrospectively reviewed. All patients underwent unenhanced and contrast-enhanced CT scanning.

RESULTS: Patient age (46.4 ± 11.1 years vs. 58.6 ± 16.0 years), tumor calcification (1/19 vs. 18/56), stalk (0/19 vs. 10/56), internal vessels (15/19 vs. 19/56) and the enlarged adjacent supplying artery (14/19 vs. 10/56) were significantly different between BPG and bladder cancer (P < 0.05). The CT value in the corticomedullary phase (92.4 ± 16.6 HU vs. 64.0 ± 14.5 HU) and the contrast-enhanced value in the corticomedullary phase (54.5 ± 17.4 HU vs. 28.5 ± 12.8 HU) were significantly greater in BPG patients than in bladder cancer patients (P < 0.001), with corresponding area under the curve values of 0.930 and 0.912, respectively. The optimal cutoff values were 83.2 HU and 38.5 HU, respectively. A CT value > 83.2 HU in the corticomedullary phase and a contrast-enhanced CT value > 38.5 HU in the corticomedullary phase were used to indicate BPG with sensitivities of 78.9% and 89.5%, respectively, and specificities of 94.6% and 75.0%, respectively.

CONCLUSION: The corticomedullary phase of CECT plays an important role in the preoperative differential diagnosis of BPG and bladder cancer.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Liang JP, Yin L, Gao LK, et al. Contrast-enhanced CT in the differential diagnosis of bladder cancer and paraganglioma. Abdom Radiol (NY). 2024. PMID: 38502213. doi:10.1007/s00261-024-04217-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。